Speciality Medicines
30 Mar '26SME
Min. Investment
₹2,34,000
Issue size
₹29.14 Cr
GMP
Locked
Overall subscription: 0.94x
Expert verdict
IPO dates
20 Mar
Opening
24 Mar
Closing
25 Mar
Allotment
30 Mar
Listing
*Refunds will be initiated on 27 Mar '26
IPO quota
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2000 | ₹2,48,000 |
Subscription (as on 23 March 2026, 06:30 PM)
Overall0.94x
Qualified institutional buyers
Non-Institutional Buyers
Retail Investors
Employee
About company
Founded: 2021|MD: Mr Parth Goyani
- Speciality Medicines Limited is engaged in the marketing and distribution of finished formulations of speciality pharmaceutical products used in the treatment of complex and chronic medical conditions. These products are primarily used in therapeutic areas such as oncology, immunology, neurology, and rare diseases.
- The company offers a portfolio of speciality medicines available in multiple dosage forms, including tablets, capsules, syrups, injections, infusions, inhalers, creams, gels, ointments, eye drops, nasal sprays, oral solutions, and suspensions.
- Its operations follow two integrated models: contract manufacturing of approved finished formulations through third-party manufacturers in India for international distribution and marketing and distribution of speciality pharmaceutical products sourced from manufacturers.
- Under the distribution model, the company handles procurement, warehousing, and wholesale supply of medicines to healthcare providers and retailers.
- As of March 31, 2025, the company’s portfolio included more than 900 products, and its distribution network covered more than 20 states in India and over 35 countries globally.
Issue Details & Objective
Lot size
1000 Shares
Price band
₹117 to 124
Face value
₹10 per share
Financials
Download DRHP (IPO Doc)FAQs
Should I apply for the Speciality Medicines IPO?
Our SEBI-registered investment advisors give out verdicts for each IPO. You can refer to their expert verdict at the top of this page. Please note that these verdicts are for informational purposes only and should not be construed as investment advice. Markets are subject to risk, and investors should exercise their own discretion and diligence.
What is the issue size of Speciality Medicines IPO?
The issue size of Speciality Medicines IPO is ₹29.14 Cr
What are the open and close dates for Speciality Medicines IPO?
The Speciality Medicines IPO will be open for applications from 20 Mar '26 to 24 Mar '26
What is the lot size and minimum order quantity of Speciality Medicines IPO?
The lot size of Speciality Medicines IPO is 1000 Shares and its minimum investment amount is ₹2,34,000.
What is the GMP value of Speciality Medicines IPO?
Grey market premium (GMP) is a premium amount at which grey market IPO shares are traded before they get listed in the stock exchange. The GMP for Speciality Medicines IPO is 0
